In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer


	. The excised tumors at the experimental end with different formulations, normal saline (G1), CBL solution (G2), non-targeted (G3), and targeted (G4) formulations.

Part of: Sahib AS, Wennas ON, Mahdi BW, Al abood RM (2022) In vivo antitumor activity study of targeted chlorambucil-loaded nanolipid carrier for breast cancer. Pharmacia 69(3): 631-636. https://doi.org/10.3897/pharmacia.69.e85390